drugset / Trial / NCT00387569

Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Healthy Toddlers

NCT00387569 ↗

Phase 1 Completed 99 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedParallel-groupTriple-blindPrevention

Summary

A study to assess the safety of an investigational meningitis vaccine in toddlers and their immune response to it.

Timeline

Start
2006-10
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject rLP8026 Unknown 20 ug —
Subject rLP8026 Unknown 60 ug —
Subject rLP8026 Unknown 200 ug —

Indications

No indication recorded.